Changes in pediatric seizure-related emergency department attendances during COVID-19 - A territory-wide

Ting Gee Annie Chiu1, William C Y Leung2, Qiqi Zhang3

  • 1Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong.

Insights

COVID-19 pandemic measures significantly reduced pediatric emergency visits for seizures, especially in young children (0-6 years). Infection control strategies show promise in preventing seizures and related emergency department visits.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Disease Epidemiology
  • Public Health Policy

Background:

  • The COVID-19 pandemic prompted widespread implementation of infection control measures.
  • Understanding the impact of these measures on non-COVID-19 related healthcare utilization is crucial.

Purpose of the Study:

  • To assess changes in pediatric seizure-related accident and emergency (A&E) department visits during the COVID-19 pandemic in Hong Kong.
  • To compare these changes with pre-pandemic periods (2015-2019) and analyze age-specific trends.

Main Methods:

  • Retrospective observational study using territory-wide data from Hong Kong.
  • Analysis of A&E attendances for pediatric seizure-related visits between January 23 and April 22, 2020.
  • Comparison with data from the same periods in 2015-2019.

Main Results:

  • A significant decrease in all-cause pediatric A&E attendances was observed during the study period.
  • Seizure-related A&E visits decreased significantly across all pediatric age groups (RR 0.379).
  • The 0-6 years age group showed a disproportionately larger decrease (RR 0.303) compared to the 7-18 years age group (RR 0.534).
  • Respiratory tract infection (RTI)-related A&E visits also decreased more drastically in the 0-6 years group.

Conclusions:

  • The findings suggest that infection control measures during the COVID-19 pandemic may have played a role in reducing pediatric seizure-related emergency visits.
  • The trend is particularly evident in younger children (0-6 years), indicating potential benefits of these measures for seizure prevention in this demographic.
  • The congruence of seizure and RTI trends in younger children supports the hypothesis that reduced transmission of infections contributed to fewer seizures.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
920
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
141
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
117
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
93
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
116